Skip to content

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Chronic Pancreatitis: An Exploratory Study

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Chronic Pancreatitis: An Exploratory Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111305
Enrollment
Unknown
Registered
2025-10-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pancreatitis

Interventions

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-60; 2. Diagnosed with chronic pancreatitis; 3. Fecal elastase (FE1) level <= 200 µg/g; 4. Still experiencing bloating and diarrhea symptoms after treatment with enteric-coated pancreatic enzyme capsules.

Exclusion criteria

Exclusion criteria: 1. Use of antibiotics or probiotics within 2 months; 2. Autoimmune pancreatitis; 3. Obstructive jaundice; 4. Uncontrolled malignant tumors; 5. Organic gastrointestinal diseases or history of gastrointestinal surgery; 6. Pregnancy or breastfeeding; 7. Mental disorders or other reasons preventing tolerance or cooperation with treatment; 8. Failure to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Quality of Life;

Secondary

MeasureTime frame
Rate of adverse events;pancreatic exocrine function;Small intestinal bacterial overgrowth (SIBO);Clinical symptoms and signs;Microbiota colonization rate;Gut microbiome metabolome;Gut microbiota composition;Gut virome;Inflammatory markers;Nutritional markers;

Countries

China

Contacts

Public ContactDong Wu

Peking Union Medical College Hospital

wudong@pumch.cn+86 10 69155017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026